Lenox Equity Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

Lenox Equity Partners’ most common sectors for investment arechemicals (25%) and electrical equipment (25%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (75%) and recapitalization (25%). In total, Lenox Equity Partners has invested in 3 US states.

The Firm’s most common exit type is trade sale (100%). Lenox Equity Partners’ largest (disclosed) exit occurred in 2016 when it sold ESP/SurgeX for $130M.

Join Mergr to view Lenox Equity Partners’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity4
    • M&A Sell Activity1
  • Total Sectors Invested 4
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 7

Lenox Equity Partners LP

3384 Peachtree Road, NE, Suite 300,
Atlanta, Georgia 30326
United States
(404) 419-1660
www.lenoxequitypartners.com
info@lenoxgroupllc.com

Lenox Equity Partners is a private equity firm focused on investing in late-stage, mature companies. Lenox looks for privately-held companies as well as non-core divestitures and is willing to invest across the capital structure, including common/preferred equity commitments and mezzanine debt. Target businesses generally have revenues of $10 to $25 million and EBITDA of $1 to $5 million. Sectors of interest include healthcare services, chemical/mineral products and processing, rubber/plastic products, metal fabrication, industrial/commercial machinery, electronics, measuring instruments, and value-added distribution. Lenox Equity Partners is based in Atlanta, Georgia.


Investment Criteria

Sectors of Interest: Business Services, Chemicals, Distribution, Electrical Equipment, Electronics, Healthcare Services, Machinery, Manufacturing, Medical Products, Plastics, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Recapitalization, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 10 25
Target EBITDA 1 5
Investment Size - -
Enterprise Value 10 50
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.0/yr) # 4 - - - - - 4
Sell (0.0/yr) # 1 - - - - - 1
vol $130M $130M
  5

Most Recent M&A

Company Date Value Type
ESP/SurgeX 2016-02-05 130M USD Add-on Acquisition
Knightdale, North Carolina · www.espsurgex.com
Crown Carbon Reduction Technologies 2012-12-14 - Recapitalization
Gillette, Wyoming · www.crown-crt.com
American BioCare, Inc. 2012-01-01 - Buyout (LBO, MBO, MBI)
Troy, United States · www.ambiocare.com
ESP/SurgeX 2008-01-11 - Buyout (LBO, MBO, MBI)
Knightdale, North Carolina · www.espsurgex.com
Medical Modalities LLC 2005-10-28 - Buyout (LBO, MBO, MBI)
Concord, North Carolina · www.medicalmodalities.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Chemicals 1 (33%) - 1 (25%) -
Electrical Equipment - - 1 (25%) -
Healthcare Services 1 (33%) - 1 (25%) -
Medical Products 1 (33%) - 1 (25%) -
Total 3 - 4 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 3 (100%) - 4 (100%) -
  North Carolina 1 (33%) - 2 (50%) -
  Wyoming 1 (33%) - 1 (25%) -
Total 3 - 4 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 2 (67%) - 3 (75%) -
Recapitalization 1 (33%) - 1 (25%) -
Total 3 - 4 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 1 (100%) 130M (100%)
Total 1 $130M

Deal Values

sell # Total
$100M to $1B 1 $130M
TOTAL $130M
Largest ESP/SurgeX
$130M (2016-02-05)

M&A Connections

Deals
Exited to
Strategic(s)
100%
1 (100%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2006

Specialist/Generalist

Generalist

Leadership

James Fite

Partner

Thomas Ledford

Partner

Mark McKee

Senior Vice President

Richelle Terry

Senior Vice President

 Subscribe to unlock this and 185,641
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 176K M&A Transactions
  • 181K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 66K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal